EUVIMEDEUVIMED entdecken
Crossref

S100A8/A9 perturbation in bone marrow blunts antitumor immunity by promoting protumorigenic myelopoiesis in mouse models

Wen Luo iD, Xingxing Su iD, Qiao Zhang iD, Zhongyu Wang, Zheng Jin iD, Yanan Li, Yang Fei iD, Dong Zeng, Xianghua Zeng, Guitong Lv iD, Mengyi Li iD, Jiani Huang und 5 weitere

Science Translational Medicine · 2025

DOI: 10.1126/scitranslmed.adr3963 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Translational Medicine, 2025. Verfasst von Wen Luo und 16 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cancer, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, P.R. China. Hauptthemen laut MEDLINE: Calgranulin B, Calgranulin A, Myelopoiesis, Bone Marrow. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 56 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

S100A8/A9 plays a critical role in the formation of an immunosuppressive tumor microenvironment. Therefore, it is important to identify inhibitors targeting S100A8/A9 to enhance antitumor immunity. However, systemic targeting of S100A8/A9 in clinical trials has shown minimal effects. Understanding the reasons underlying this underperformance is important for developing drugs targeting S100A8/A9 that could effectively reverse the immunosuppressive tumor microenvironment. In this study, using hematopoietic system–specific conditional knockout mice in heterotopic models of lung and colon cancer and systemic pharmacological interference, we demonstrated that S100A8/A9 perturbation in the hematopoietic system accelerates tumor progression by attenuating T cell–mediated antitumor immunity. Mechanistically, S100A8/A9 perturbation triggered myeloid-biased differentiation in the bone marrow by promoting the production of abnormal granulocyte-monocyte progenitors. The local release of S100A8/A9 inhibitors using a tumor-targeted drug delivery system exhibited antitumor potential by avoiding myelopoiesis-promoting effects. These findings reveal a mechanism underlying the limited efficacy of systemic S100A8/A9 inhibition and propose a targeted strategy to enhance antitumor effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Calgranulin BCalgranulin AMyelopoiesisBone MarrowCarcinogenesisAnimalsDisease Models, AnimalMiceTumor MicroenvironmentMice, KnockoutMice, Inbred C57BLCell Differentiation

Substanzen

Calgranulin BCalgranulin AS100A9 protein, mouse

Autor:innen und Institutionen

  • Institute of Cancer, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, P.R. China.
  • Chongqing Key Laboratory of Immunotherapy, Chongqing 400037, P.R. China.
  • Department of Respiration, Hospital of the Coast Guard Corps of the Chinese People's Armed Police Force, Zhejiang 314000, P.R. China.
  • Department of Hematology and Oncology, 988th Hospital of Joint Logistic Support Force of PLA, Zhengzhou 450042, P.R. China.
  • Institute of Immunological Innovation and Translation, Chongqing Medical University, Chongqing 400016, P.R. China.
  • School of Life Science, Chongqing University, Chongqing 400044, P.R. China.

ORCID-Profile: Wen Luo, Xingxing Su, Qiao Zhang, Zheng Jin, Yang Fei, Guitong Lv, Mengyi Li, Haoran Zha, Ji Liu, Zhong Luo, Haixia Long, Bo Zhu

Zitieren

APA

Luo, W., Su, X., Zhang, Q., Wang, Z., Jin, Z., Li, Y., Fei, Y., Zeng, D., Zeng, X., Lv, G., Li, M., Huang, J., Zha, H., Liu, J., Luo, Z., Long, H., & Zhu, B. (2025). S100A8/A9 perturbation in bone marrow blunts antitumor immunity by promoting protumorigenic myelopoiesis in mouse models. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.adr3963

Vancouver

Luo W, Su X, Zhang Q, Wang Z, Jin Z, Li Y, et al. S100A8/A9 perturbation in bone marrow blunts antitumor immunity by promoting protumorigenic myelopoiesis in mouse models. Science Translational Medicine. 2025. doi:10.1126/scitranslmed.adr3963

BibTeX
@article{Luo2025,
  author = {Luo, Wen and Su, Xingxing and Zhang, Qiao and Wang, Zhongyu and Jin, Zheng and Li, Yanan and Fei, Yang and Zeng, Dong and Zeng, Xianghua and Lv, Guitong and Li, Mengyi and Huang, Jiani and Zha, Haoran and Liu, Ji and Luo, Zhong and Long, Haixia and Zhu, Bo},
  title = {S100A8/A9 perturbation in bone marrow blunts antitumor immunity by promoting protumorigenic myelopoiesis in mouse models},
  journal = {Science Translational Medicine},
  year = {2025},
  doi = {10.1126/scitranslmed.adr3963}
}
Kostenlos starten →